Annex Ib : Final CSP (clean version)
Annex I: FINAL CSP
ANNEX I TO PSUR CORE SAFETY PROFILE (EU SPC Sections 4.2
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
Annex I : CSP – final clean version
Annex 4 EPI Forms v4
Annex 2 Spice And RA - European Monitoring Centre for Drugs and
Annex 2
Annex 1 - The plant and the drug - United Nations Office on Drugs
Annex 1 - Emcdda
Annex 1 - Emcdda
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE
ANNE ARUNDEL MEDICAL CENTER
Ann N Y Acad Sci
Ankylosing spondylitis – The history of medical therapies
